UroGen Pharma Ltd URGN
NAS: URGN | ISIN: IL0011407140 30/04/2025
11,64 USD (+8,18%)
(+8,18%)
30/04/2025
Profiel UroGen Pharma Ltd
CEO: Elizabeth Barrett
Werknemers: 206